Microscopic features of colorectal neoplasia in inflammatory bowel diseases
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (12) , 3164-72
Abstract
The risk of developing dysplasia leading to colorectal cancer (CRC) is increased in both ulcerative colitis and Crohn's disease. The prognosis of CRC may be poorer in patients with inflammatory bowel disease (IBD) than in those without IBD. Most CRCs, in general, develop from a dysplastic precursor lesion. The interpretation by the pathologist of the biopsy will guide decision making in clinical practice: colonoscopic surveillance or surgical management. This review summarizes features of dysplasia (or intraepithelial neoplasia) with macroscopic and microscopic characteristics. From an endoscopic (gross) point of view, dysplasia may be classified as flat or elevated (raised); from a histological point of view, dysplasia is separated into 3 distinct categories: negative for dysplasia, indefinite for dysplasia, and positive for dysplasia with low- or high-grade dysplasia. The morphologic criteria for dysplasia are based on a combination of cytologic (nuclear and cytoplasmic) and architectural aberrations of the crypt epithelium. Immunohistochemical and molecular markers for dysplasia are reviewed and may help with dysplasia diagnosis, although diagnosis is essentially based on morphological criteria. The clinical, epidemiologic, and pathologic characteristics of IBD-related cancers are, in many aspects, different from those that occur sporadically in the general population. Herein, we summarize macroscopic and microscopic features of IBD-related colorectal carcinoma.Keywords
This publication has 94 references indexed in Scilit:
- Management of Neoplastic Polyps in Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2003
- Colonic dysplasia and cancer in inflammatory bowel diseaseGastrointestinal Endoscopy Clinics of North America, 2002
- Screening and surveillance colonoscopy in chronic Crohn's colitisGastroenterology, 2001
- Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis‐related dysplasiaHistopathology, 2000
- Lymphoepithelioma-like carcinoma of the rectum in a patient with ulcerative colitis.1996
- Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitisGastroenterology, 1994
- Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.1994
- Crohn's disease and carcinomaDiseases of the Colon & Rectum, 1992
- Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.1992
- Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomyGastroenterology, 1981